Paper Details

Paper Title

SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.

Paper Journal Title

J Clin Invest

Paper Citation Count

Paper Publication Year

2018

Bio Mention

E3 ubiquitin ligase, ERG, ERG protein, SPOP, SPOP mutation, SPOP mutations, SPOP-mutant, SPOP-mutant and ERG-fusion organoid models, SPOP-mutant cancers, SPOP-mutant prostate cancer, high-grade prostatic intraepithelial neoplasia, human, invasive adenocarcinoma, mouse, oncogenic transcription factor ERG, prostate cancer, prostate cancers, prostate neoplasia, transcription factor ERG, ubiquitin ligase

Mesh Descriptor

Author Name	Affiliation
Mirjam Blattner	Sandra and Edward Meyer Cancer Center
Mirjam Blattner
Andrea Sboner	HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine.
Andrea Sboner	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Andrea Sboner
Andrea Sboner	HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine.
Andrea Sboner	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Andrea Sboner
Kyung Park
Kyung Park
Brian D Robinson	New York Presbyterian Hospital.
Brian D Robinson
Juan Miguel Mosquera
Juan Miguel Mosquera	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Juan Miguel Mosquera
Juan Miguel Mosquera	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Yu Chen
Yu Chen
Yu Chen	Memorial Sloan Kettering Cancer Center
Mark A Rubin	New York Presbyterian Hospital.
Mark A Rubin	University of Bern
Mark A Rubin	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Mark A Rubin
Mark A Rubin	Sandra and Edward Meyer Cancer Center
Mark A Rubin	New York Presbyterian Hospital.
Mark A Rubin	University of Bern
Mark A Rubin	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Mark A Rubin
Mark A Rubin	Sandra and Edward Meyer Cancer Center
Christopher E Barbieri	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital
Christopher E Barbieri	New York Presbyterian Hospital.
Christopher E Barbieri	Sandra and Edward Meyer Cancer Center
Christopher E Barbieri	New York Presbyterian Hospital.
Christopher E Barbieri	Sandra and Edward Meyer Cancer Center
Christopher E Barbieri	The Caryl and Israel Englander Institute for Precision Medicine of Weill Cornell Medicine, and New York-Presbyterian Hospital

1 - 35

Paper Details

Column Actions

Datasets